Haoxuan Huang

461 Bayi Avenue
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.

MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.

Journal: Research (Washington, D.C.)

Published: April 15, 2026

The ZIF-8 nanoplatform targeted delivery of IFI44 siRNA to suppress bladder cancer development via modulating the PI3K/AKT signaling pathway.

The ZIF-8 nanoplatform targeted delivery of IFI44 siRNA to suppress bladder cancer development via modulating the PI3K/AKT signaling pathway.

Journal: Journal of nanobiotechnology

Published: November 19, 2025

Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling.

Lymph Node Metastasis-Associated Spatiotemporal Mapping of the TFF3-Linked Niche in Breast Cancer: Integrating Radiogenomic Signatures with Immune-Ecosystem Remodeling.

Journal: Research (Washington, D.C.)

Published: August 27, 2025

Knockdown of TIM1 enhances platinum chemosensitivity and inhibits progression through the MAPK signaling pathway in gastric cancer.

Knockdown of TIM1 enhances platinum chemosensitivity and inhibits progression through the MAPK signaling pathway in gastric cancer.

Journal: American journal of translational research

Published: November 07, 2024

A radiogenomic multimodal and whole-transcriptome sequencing for preoperative prediction of axillary lymph node metastasis and drug therapeutic response in breast cancer: a retrospective, machine learning and international multicohort study.

A radiogenomic multimodal and whole-transcriptome sequencing for preoperative prediction of axillary lymph node metastasis and drug therapeutic response in breast cancer: a retrospective, machine learning and international multicohort study.

Journal: International journal of surgery (London, England)

Published: October 02, 2023

Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.

Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.

Journal: Scientific reports

Published: July 19, 2023

High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer.

High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer.

Journal: BMC urology

Published: December 03, 2022

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.

Journal: BMC cancer

Published: November 08, 2022

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.

IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.

Journal: BMC cancer

Published: May 06, 2022

Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma.

Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma.

Journal: Cell transplantation

Published: February 18, 2022

ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma.

ORC6 acts as a biomarker and reflects poor outcome in clear cell renal cell carcinoma.

Journal: Journal of Cancer

Published: January 22, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026